PHARMACYTE BIOTECH INC's ticker is PMCB and the CUSIP is 71715X104. A total of 7 filers reported holding PHARMACYTE BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 40,000 | $268 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| Fisher Asset Management, LLC | 401,553 | $3,000 | 0.00% |
| Peregrine Asset Advisers, Inc. | 20,000 | $0 | 0.00% |